Unicycive Therapeutics (UNCY) Other Operating Expenses (2020 - 2023)

Unicycive Therapeutics (UNCY) has 4 years of Other Operating Expenses data on file, last reported at $1.6 million in Q3 2023.

• Quarterly Other Operating Expenses rose 53600.0% year-over-year to $1.6 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $1.6 million (up 108.83% YoY) and the FY2021 annual result came in at $5.4 million, up 199.72% from the prior year.
• Other Operating Expenses rose to $1.6 million in Q3 2023, from $484000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $4.5 million in Q3 2021 to a low of -$10.4 million in Q1 2023.
• A 4-year average of -$619818.2 and a median of $484000.0 in 2023 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 53600.0% in 2023, down 834.11% in 2023.
• Tracing UNCY's Other Operating Expenses over 4 years: stood at $646000.0 in 2020, then jumped by 339.63% to $2.8 million in 2021, then sank by 392.01% to -$8.3 million in 2022, then jumped by 119.35% to $1.6 million in 2023.
• The last three Other Operating Expenses figures came in at $1.6 million (Q3 2023), $484000.0 (Q2 2023), and -$10.4 million (Q1 2023), per Business Quant data.